Performance improvements of stool-based screening tests

Best Practice and Research: Clinical Gastroenterology

Volumn 24, Issue 4, 2010, Pages 479-492

  Van Dam, Leonie ^a   Kuipers, Ernst J ^a   Van Leerdam, Monique E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adenomas; Colorectal cancer; Faecal DNA test; Faecal immunochemical test; FIT; FOBT; Guaiac based faecal occult blood test; Performance; Screening

Indexed keywords

DNA; GUAIAC;

CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DNA DETERMINATION; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; HUMAN; OCCULT BLOOD TEST; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS;

EID: 77956600637     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2010.03.009     Document Type: Article

References (109)

1. Commission of the European Communities Brussels. Council Recommendation on Cancer Screening. 2003. Report No.: 2003/0093.
2. B. Levin, D.A. Lieberman, B. McFarland, K.S. Andrews, D. Brooks, and J. Bond Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology 134 5 2008 May 1570 1595 (Pubitemid 351615355)
3. J.J. Sung, J.Y. Lau, G.P. Young, Y. Sano, H.M. Chiu, and J.S. Byeon Asia Pacific consensus recommendations for colorectal cancer screening Gut 57 8 2008 Aug 1166 1176
4. J.E. Allison, L.C. Sakoda, T.R. Levin, J.P. Tucker, I.S. Tekawa, and T. Cuff Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics J Natl Cancer Inst 99 19 2007 Oct 3 1462 1470
5. L. Guittet, V. Bouvier, N. Mariotte, J.P. Vallee, D. Arsene, and S. Boutreux Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population Gut 56 2 2007 Feb 210 214
6. L. Guittet, V. Bouvier, N. Mariotte, J.P. Vallee, R. Levillain, and J. Tichet Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location Br J Cancer 100 8 2009 Apr 21 1230 1235
7. L. Hol, M.E. van Leerdam, Ballegooijen. M. van, A.J. van Vuuren, D.H. van, and J.C. Reijerink Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy Gut 59 1 2010 Jan 62 68
8. S. Hundt, U. Haug, and H. Brenner Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection Ann Intern Med 150 3 2009 Feb 3 162 169
9. L.G. van Rossum, A.F. Van Rijn, R.J. Laheij, M.G. van Oijen, P. Fockens, and H.H. Van Krieken Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population Gastroenterology 2008 Mar 25
10. D. Lieberman Colon cancer screening and surveillance controversies Curr Opin Gastroenterol 25 5 2009 Sep 422 427
11. D.A. Ahlquist Next-generation stool DNA testing: expanding the scope Gastroenterology 136 7 2009 Jun 2068 2073
12. D.L. Ouyang, J.J. Chen, R.H. Getzenberg, and R.E. Schoen Noninvasive testing for colorectal cancer: a review Am J Gastroenterol 100 6 2005 Jun 1393 1403
13. G.P. Young Population-based screening for colorectal cancer: Australian research and implementation J Gastroenterol Hepatol 24 Suppl. 3 2009 Oct S33 S42
14. M.A. Sinatra, D.J. St John, and G.P. Young Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable Clin Chem 45 1 1999 Jan 123 126
15. M. Pignone, M.K. Campbell, C. Carr, and C. Phillips Meta-analysis of dietary restriction during fecal occult blood testing Eff Clin Pract 4 4 2001 Jul 150 156
16. P.D. Greenberg, J.P. Cello, and D.C. Rockey Relationship of low-dose aspirin to GI injury and occult bleeding: a pilot study Gastrointest Endosc 50 5 1999 Nov 618 622
17. C.J. Kahi, and T.F. Imperiale Do aspirin and nonsteroidal anti-inflammatory drugs cause false-positive fecal occult blood test results? A prospective study in a cohort of veterans Am J Med 117 11 2004 Dec 1 837 841
18. European Commission. European guidelines for quality assurance in colorectal cancer screening, in press.
19. J.F. Collins, D.A. Lieberman, T.E. Durbin, and D.G. Weiss Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice Ann Intern Med 142 2 2005 Jan 18 81 85
20. J.E. Allison, I.S. Tekawa, L.J. Ransom, and A.L. Adrain A comparison of fecal occult-blood tests for colorectal-cancer screening N Engl J Med 334 3 1996 Jan 18 155 159
21. B. Levin, K. Hess, and C. Johnson Screening for colorectal cancer. A comparison of 3 fecal occult blood tests Arch Intern Med 157 9 1997 May 12 970 976
22. D.A. Lieberman, and D.G. Weiss One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon N Engl J Med 345 8 2001 Aug 23 555 560
23. J.S. Mandel, J.H. Bond, T.R. Church, D.C. Snover, G.M. Bradley, and L.M. Schuman Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Studyh N Engl J Med 328 19 1993 May 13 1365 1371
24. Suggested technique for fecal occult blood testing and interpretation in colorectal cancer screening. American College of Physicians Ann Intern Med 126 10 1997 May 15 808 810
25. J.B. Simon Occult blood screening for colorectal carcinoma: a critical review Gastroenterology 88 3 1985 Mar 820 837
26. H. Faure, C. Exbrayat, and P. Winckel Moisture content of Hemoccult slides influences test sensitivity Eur J Gastroenterol Hepatol 15 10 2003 Oct 1111 1114
27. O. Kronborg, C. Fenger, J. Olsen, O.D. Jorgensen, and O. Sondergaard Randomised study of screening for colorectal cancer with faecal-occult-blood test Lancet 348 9040 1996 Nov 30 1467 1471
28. S. Li, H. Wang, J. Hu, N. Li, Y. Liu, and Z. Wu New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients Int J Cancer 118 12 2006 Jun 15 3078 3083
29. J.S. Mandel, T.R. Church, J.H. Bond, F. Ederer, M.S. Geisser, and S.J. Mongin The effect of fecal occult-blood screening on the incidence of colorectal cancer N Engl J Med 343 22 2000 Nov 30 1603 1607
30. G. Rennert, H.S. Rennert, E. Miron, and Y. Peterburg Population colorectal cancer screening with fecal occult blood test Cancer Epidemiol Biomarkers Prev 10 11 2001 Nov 1165 1168
31. J.D. Hardcastle, J.O. Chamberlain, M.H. Robinson, S.M. Moss, S.S. Amar, and T.W. Balfour Randomised controlled trial of faecal-occult-blood screening for colorectal cancer Lancet 348 9040 1996 Nov 30 1472 1477
32. Weller D, Moss S, Butler P, Campbell C. Coleman D. Melia J. et al. English Pilot of Bowel Cancer Screening: an evaluation of the second round. Final Report to the Department of Health. 2006.
33. M. Fleisher, S.J. Winawer, A.G. Zauber, C. Smith, and M.K. Schwartz Accuracy of fecal occult blood test interpretation. National Polyp Study Work Group Ann Intern Med 114 10 1991 May 15 875 876
34. R.R. Selinger, S. Norman, and J.A. Dominitz Failure of health care professionals to interpret fecal occult blood tests accurately Am J Med 114 1 2003 Jan 64 67
35. L. Rabeneck, C. Zwaal, J.H. Goodman, V. Mai, and M. Zamkanei Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: evidentiary base and recommendations Clin Biochem 41 16-17 2008 Nov 1289 1305
36. T.F. Imperiale, D.F. Ransohoff, S.H. Itzkowitz, B.A. Turnbull, and M.E. Ross Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population N Engl J Med 351 26 2004 Dec 23 2704 2714
37. J.J. Sung, F.K. Chan, W.K. Leung, J.C.Y. Wu, J.Y.W. Lau, and J. Ching Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy Gastroenterology 124 3 2003 Mar 608 614
38. P. Hewitson, P. Glasziou, and E. Watson Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update Am J Gastroenterol 103 6 2008 Jun 1541 1549
39. V. Dancourt, C. Lejeune, C. Lepage, M.C. Gailliard, B. Meny, and J. Faivre Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms Eur J Cancer 44 15 2008 Oct 2254 2258
40. L.G. van Rossum, A.F. Van Rijn, R.J. Laheij, M.G. van Oijen, P. Fockens, and H.H. Van Krieken Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population Gastroenterology 135 1 2008 Jul 82 90
41. J. Potack, and S.H. Itzkowitz Practical advances in stool screening for colorectal cancer J Natl Compr Canc Netw 8 1 2010 Jan 81 92
42. U. Haug, S. Hundt, and H. Brenner Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests Am J Gastroenterol 2009 Dec 1
43. A. Sieg, C. Thoms, K. Luthgens, M.R. John, and H. Schmidt-Gayk Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces Int J Colorectal Dis 14 6 1999 Dec 267 271
44. Z. Levi, P. Rozen, R. Hazazi, A. Vilkin, A. Waked, and E. Maoz Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants Am J Gastroenterol 104 4 2009 Apr 933 938
45. H. Nakama, A.S. Fattah, B. Zhang, and N. Kamijo Digital rectal examination sampling of stool is less predictive of significant colorectal pathology than stool passed spontaneously Eur J Gastroenterol Hepatol 12 11 2000 Nov 1235 1238
46. H. Nakama, B. Zhang, A.S. bdul Fattah, and N. Kamijo Does stool collection method affect outcomes in immunochemical fecal occult blood testing? Dis Colon Rectum 44 6 2001 Jun 871 875
47. B. Zhang, H. Nakama, A.S. Fattah, and N. Kamijo Lower specificity of occult-blood test on stool collected by digital rectal examination Hepatogastroenterology 49 43 2002 Jan 165 167
48. H. Brenner, U. Haug, and S. Hundt Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests Int J Cancer 2010 Jan 4
49. B. Tannous, E. Lee-Lewandrowski, C. Sharples, W. Brugge, L. Bigatello, and T. Thompson Comparison of conventional guaiac to four immunochemical methods for fecal occult blood testing: implications for clinical practice in hospital and outpatient settings Clin Chim Acta 400 1-2 2009 Feb 120 122
50. L.G. van Rossum, A.F. Van Rijn, M.G. van Oijen, P. Fockens, R.J. Laheij, and A.L. Verbeek False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening Int J Cancer 125 4 2009 Aug 15 746 750
51. A. Vilkin, P. Rozen, Z. Levi, A. Waked, E. Maoz, and S. Birkenfeld Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test Am J Gastroenterol 100 11 2005 Nov 2519 2525
52. H. Nakama, N. Kamijo, K. Fujimori, A.S. Fattah, and B. Zhang Relationship between fecal sampling times and sensitivity and specificity of immunochemical fecal occult blood tests for colorectal cancer: a comparative study Dis Colon Rectum 40 7 1997 Jul 781 784
53. H. Nakama, M. Yamamoto, N. Kamijo, T. Li, N. Wei, and A.S. Fattah Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia Hepatogastroenterology 46 25 1999 Jan 228 231
54. Z. Levi, P. Rozen, R. Hazazi, A. Vilkin, A. Waked, and E. Maoz A quantitative immunochemical fecal occult blood test for colorectal neoplasia Ann Intern Med 146 4 2007 Feb 20 244 255
55. P. Rozen, Z. Levi, R. Hazazi, A. Waked, A. Vilkin, and E. Moaz Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed Aliment Pharmacol Ther 29 8 2009 Apr 15 906 917
56. L. Guittet, V. Bouvier, N. Mariotte, J.P. Vallee, R. Levillain, and J. Tichet Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples Int J Cancer 125 5 2009 Sep 1 1127 1133
57. G. Grazzini, C.B. Visioli, M. Zorzi, S. Ciatto, F. Banovich, and A.G. Bonanomi Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer 100 2 2009 Jan 27 259 265
58. H. Nakama, B. Zhang, and A.S. Fattah A cost-effective analysis of the optimum number of stool specimens collected for immunochemical occult blood screening for colorectal cancer Eur J Cancer 36 5 2000 Mar 647 650 (Pubitemid 30156851)
59. M. Yamamoto, and H. Nakama Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods Hepatogastroenterology 47 32 2000 Mar 396 399 (Pubitemid 30216300)
60. S. Ciatto, F. Martinelli, G. Castiglione, P. Mantellini, T. Rubeca, and G. Grazzini Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme Br J Cancer 96 2 2007 Jan 29 218 221
61. J.B. Edwards Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value Pathology 37 6 2005 Dec 565 568
62. P. Rozen, A. Waked, A. Vilkin, Z. Levi, and Y. Niv Evaluation of a desk top instrument for the automated development and immunochemical quantification of fecal occult blood Med Sci Monit 12 6 2006 Jun MT27 MT32
63. L. Hol, J.A. Wilschut, Ballegooijen. M. van, A.J. van Vuuren, H. van der Valk, and J.C. Reijerink Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels Br J Cancer 100 7 2009 Apr 7 1103 1110
64. G. Castiglione, G. Grazzini, G. Miccinesi, T. Rubeca, C. Sani, and P. Turco Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood J Med Screen 9 3 2002 99 103
65. L.S. Chen, C.S. Liao, S.H. Chang, H.C. Lai, and T.H. Chen Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16) J Med Screen 14 4 2007 191 199
66. C.G. Fraser, C.M. Mathew, K. McKay, F.A. Carey, and R.J. Steele Automated immunochemical quantitation of haemoglobin in faeces collected on cards for screening for colorectal cancer Gut 57 9 2008 Sep 1256 1260
67. G.D. Launoy, H.J. Bertrand, C. Berchi, V.Y. Talbourdet, A.V. Guizard, and V.M. Bouvier Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population Int J Cancer 115 3 2005 Jun 20 493 496 (Pubitemid 40663756)
68. H. Nakama, B. Zhang, and X. Zhang Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer Eur J Cancer 37 3 2001 Feb 398 401
69. L.G. van Rossum, A.F. Van Rijn, R.J. Laheij, M.G. van Oijen, P. Fockens, and J.B. Jansen Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme Br J Cancer 101 8 2009 Oct 20 1274 1281
70. W.M. Wong, S.K. Lam, K.L. Cheung, T.S. Tong, P. Rozen, and G.P. Young Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population Cancer 97 10 2003 May 15 2420 2424 (Pubitemid 36542480)
71. J. Ferlay, P. Autier, and M. Boniol Estimates of the cancer incidence and mortality in Europe in 2006 Ann Oncol 18 3 2007 Mar 581 592
72. E.P. Whitlock, J.S. Lin, E. Liles, T.L. Beil, and R. Fu Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force Ann Intern Med 149 9 2008 Nov 4 638 658
73. G. Castiglione, M. Zappa, G. Grazzini, C. Sani, A. Mazzotta, and P. Mantellini Cost analysis in a population based screening programme for colorectal cancer: comparison of immunochemical and guaiac faecal occult blood testing J Med Screen 4 3 1997 142 146
74. A. Federici, R.P. Giorgi, P. Borgia, F. Bartolozzi, S. Farchi, and G. Gausticchi The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial J Med Screen 12 2 2005 83 88
75. C.W. Ko, J.A. Dominitz, and T.D. Nguyen Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests Am J Med 115 2 2003 Aug 1 111 114
76. Z. Levi, R. Hazazi, P. Rozen, A. Vilkin, A. Waked, and Y. Niv A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test Aliment Pharmacol Ther 23 9 2006 May 1 1359 1364
77. P. Rozen, Z. Levi, R. Hazazi, A. Waked, A. Vilkin, and E. Maoz Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms Aliment Pharmacol Ther 29 4 2009 Feb 15 450 457
78. A. Smith, G.P. Young, S.R. Cole, and P. Bampton Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia Cancer 107 9 2006 Nov 1 2152 2159
79. B.C. Wong, W.M. Wong, K.L. Cheung, T.S. Tong, P. Rozen, and G.P. Young A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population Aliment Pharmacol Ther 18 9 2003 Nov 1 941 946
80. M. Zappa, G. Castiglione, E. Paci, G. Grazzini, T. Rubeca, and P. Turco Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience Int J Cancer 92 1 2001 Apr 1 151 154
81. S.R. Cole, G.P. Young, A. Esterman, B. Cadd, and J. Morcom A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer J Med Screen 10 3 2003 117 122
82. C.G. Fraser, C.M. Mathew, N.A. Mowat, J.A. Wilson, F.A. Carey, and R.J. Steele Evaluation of a card collection-based faecal immunochemical test in screening for colorectal cancer using a two-tier reflex approach Gut 56 10 2007 Oct 1415 1418
83. P.D. Greenberg, L. Bertario, R. Gnauck, O. Kronborg, J.D. Hardcastle, and M.S. Epstein A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy Am J Gastroenterol 95 5 2000 May 1331 1338
84. N.K. Osborn, and D.A. Ahlquist Stool screening for colorectal cancer: molecular approaches Gastroenterology 128 1 2005 Jan 192 206
85. F. Diehl, K. Schmidt, K.H. Durkee, K.J. Moore, S.N. Goodman, and A.P. Shuber Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients Gastroenterology 135 2 2008 Aug 489 498
86. H. Zou, W.R. Taylor, J.J. Harrington, F.T. Hussain, X. Cao, and C.L. Loprinzi High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay Gastroenterology 136 2 2009 Feb 459 470
87. J. Olson, D.H. Whitney, K. Durkee, and Shuber A.P. DNA stabilization is critical for maximizing performance of fecal DNA-based colorectal cancer tests Diagn Mol Pathol 14 3 2005 Sep 183 191
88. D.A. Ahlquist, J.E. Skoletsky, K.A. Boynton, J.J. Harrington, D.W. Mahoney, and W.E. Pierceall Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel Gastroenterology 119 5 2000 Nov 1219 1227
89. D.A. Ahlquist, D.J. Sargent, C.L. Loprinzi, T.R. Levin, D.K. Rex, and D.J. Ahnen Stool DNA and occult blood testing for screen detection of colorectal neoplasia Ann Intern Med 149 7 2008 Oct 7 441 450 W81
90. D. Calistri, C. Rengucci, R. Bocchini, L. Saragoni, W. Zoli, and D. Amadori Fecal multiple molecular tests to detect colorectal cancer in stool Clin Gastroenterol Hepatol 1 5 2003 Sep 377 383
91. K.S. Tagore, M.J. Lawson, J.A. Yucaitis, R. Gage, T. Orr, and A.P. Shuber Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia Clin Colorectal Cancer 3 1 2003 May 47 53
92. W.D. Chen, Z.J. Han, J. Skoletsky, J. Olson, J. Sah, and L. Myeroff Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene J Natl Cancer Inst 97 15 2005 Aug 3 1124 1132
93. S.H. Itzkowitz, L. Jandorf, R. Brand, L. Rabeneck, P.C. Schroy III, and S. Sontag Improved fecal DNA test for colorectal cancer screening Clin Gastroenterol Hepatol 5 1 2007 Jan 111 117
94. S. Itzkowitz, R. Brand, L. Jandorf, K. Durkee, J. Millholland, and L. Rabeneck A simplified, noninvasive stool DNA test for colorectal cancer detection Am J Gastroenterol 103 11 2008 Nov 2862 2870
95. H.M. Muller, M. Oberwalder, H. Fiegl, M. Morandell, G. Goebel, and M. Zitt Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet 363 9417 2004 Apr 17 1283 1285 (Pubitemid 38496491)
96. Z. Huang, L. Li, and J. Wang Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions Dig Dis Sci 52 9 2007 Sep 2287 2291
97. Z.H. Huang, L.H. Li, F. Yang, and Wang J.F. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions World J Gastroenterol 13 6 2007 Feb 14 950 954
98. W.K. Leung, K.F. To, E.P. Man, M.W. Chan, A.J. Hui, and S.S. Ng Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps Am J Gastroenterol 102 5 2007 May 1070 1076
99. D.R. Wang, and D. Tang Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening World J Gastroenterol 14 4 2008 Jan 28 524 531
100. T. Nagasaka, N. Tanaka, H.M. Cullings, D.S. Sun, H. Sasamoto, and T. Uchida Analysis of fecal DNA methylation to detect gastrointestinal neoplasia J Natl Cancer Inst 101 18 2009 Sep 16 1244 1258
101. Y.H. Baek, E. Chang, Y.J. Kim, B.K. Kim, J.H. Sohn, and D.I. Park Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients Dis Colon Rectum 52 8 2009 Aug 1452 1459
102. S.C. Glockner, M. Dhir, J.M. Yi, K.E. McGarvey, N.L. Van, and J. Louwagie Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer Cancer Res 69 11 2009 Jun 1 4691 4699
103. K. Lenhard, G.T. Bommer, S. Asutay, R. Schauer, T. Brabletz, and B. Goke Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer Clin Gastroenterol Hepatol 3 2 2005 Feb 142 149
104. R. Mayor, L. Casadome, D. Azuara, V. Moreno, S.J. Clark, and G. Capella Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease Br J Cancer 100 10 2009 May 19 1534 1539
105. V. Melotte, M.H. Lentjes, S.M. van den Bosch, B. Towler, and Irwig L. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer J Natl Cancer Inst 101 13 2009 Jul 1 916 927
106. Z. Petko, M. Ghiassi, A. Shuber, J. Gorham, W. Smalley, and M.K. Washington Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps Clin Cancer Res 11 3 2005 Feb 1 1203 1209
107. W. Zhang, M. Bauer, R.S. Croner, J.O. Pelz, D. Lodygin, and H. Hermeking DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene Dis Colon Rectum 50 10 2007 Oct 1618 1626
108. D. Whitney, J. Skoletsky, K. Moore, K. Boynton, L. Kann, and R. Brand Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test J Mol Diagn 6 4 2004 Nov 386 395
109. N. Kutzner, I. Hoffmann, C. Linke, T. Thienel, M. Grzegorczyk, and W. Urfer Non-invasive detection of colorectal tumours by the combined application of molecular diagnosis and the faecal occult blood test Cancer Lett 229 1 2005 Nov 8 33 41